On August 3, 2021 Magenta Therapeutics, Inc. (Nasdaq: MGTA), a clinical-stage biotechnology company developing novel medicines to bring the curative power of stem cell transplants to more patients, reported that the company will participate in the following August investor conferences (Press release, Magenta Therapeutics, AUG 3, 2021, View Source [SID1234585619]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

BTIG Virtual Biotechnology Conference, presentation at 12:00 p.m. ET on Monday, August 9
2021 Wedbush PacGrow Healthcare Virtual Conference, panel: So Let it Be (Re)Written – Updates in Gene Modulation at 9:10 a.m. ET on Tuesday, August 10
Additional information can be found on the Magenta Therapeutics website at View Source